SCHEMBL9705366

SCHEMBL9705366

COc1cc(C)ccc1-c1nc2cc3c(cc2[nH]1)C(C)(C)CNC3=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
AMY1A P0DUB6 6/20 0.42
ALOX5 P09917 1/20 0.40
EPHX2 P34913 1/20 0.40
PDE5A O76074 2/20 0.39
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
HCRTR1 O43613 3/20 0.38
HCRTR2 O43614 3/20 0.38
NPBWR1 P48145 1/20 0.38
AURKA O14965 1/20 0.36
KDR P35968 1/20 0.36
PDE2A O00408 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703298 0.87 PDE5A (0.38) AMY1APDE5APDE3BPDE3AAURKA
SCHEMBL9383861 0.86 CDK4 (0.41) AMY1APDE5APDE3BPDE3ANPBWR1
SCHEMBL9703362 0.86 PDE5A (0.37) TP53MAPTPOLBAMY1APDE5A
SCHEMBL9704386 0.85 PDE2A (0.39) MAPTPOLBAMY1APDE5APDE3B
SCHEMBL10556798 0.84 AMY1A (0.44) TP53MAPTPOLBAMY1AALOX5
SCHEMBL10697321 0.82 AMY1A (0.45) TP53MAPTPOLBAMY1APDE3B
SCHEMBL10700489 0.80 NPC1 (0.49) TP53MAPTPOLBPDE3BPDE3A
SCHEMBL9385702 0.77 PDE4A (0.59) MAPTPOLBPDE3BPDE3APDE4A
SCHEMBL9703307 0.76 PDE4A (0.34) AMY1APDE3BPDE3AAURKAKDR
SCHEMBL9703536 0.76 TP53 (0.42) TP53MAPTPOLBAMY1AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed